FLJ40194: A Potential Drug Target and Biomarker (G124871)

Target Name: FLJ40194

NCBI ID: G124871

FLJ40194

Other Name(s): Uncharacterized FLJ40194 | uncharacterized FLJ40194

FLJ40194: A Potential Drug Target and Biomarker

FLJ40194 is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. Its unique structure and location in the body suggest that it may play a critical role in the function of these tissues. As a result, FLJ40194 has been identified as a potential drug target and biomarker.

The FLJ40194 protein is characterized by its unique molecular structure. It consists of 121 amino acids and has a calculated molecular weight of 13.9 kDa. The protein is composed of a single polypeptide chain that is made up of 121 amino acids. The chain is made up of four distinct regions: an amino terminal region, a catalytic region, a carboxy terminal region, and a middle region.

TheFLJ40194 protein is located in a unique position in the body. It is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is found in the brain, where it is expressed in the cerebral cortical cortex, the basal ganglia, and the choroid plexus. It is also found in the heart, where it is expressed in the cardiac muscle. Additionally, it is found in the kidneys, where it is expressed in the glomeruli and the interstitial cells.

The FLJ40194 protein is involved in various physiological processes in the body. It is involved in the regulation of cell signaling, as well as the regulation of inflammation. It is also involved in the regulation of ion channels and the regulation of the blood pressure.

As a result of its unique structure and location, FLJ40194 has been identified as a potential drug target. The FLJ40194 protein is thought to be involved in various signaling pathways in the brain, and as a result, it may be a useful target for drugs that can modulate these signaling pathways. Additionally, its location in various tissues suggests that it may be a useful biomarker for the diagnosis and treatment of various diseases.

In conclusion, FLJ40194 is a protein that is expressed in various tissues of the human body and is involved in various physiological processes in the body. Its unique structure and location suggest that it may be a potential drug target and biomarker. Further research is needed to fully understand the role of FLJ40194 in the body and to develop effective treatments for diseases that are caused by its dysfunction.

Protein Name: Uncharacterized FLJ40194

The "FLJ40194 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FLJ40194 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets